0000950170-24-008808.txt : 20240130
0000950170-24-008808.hdr.sgml : 20240130
20240130160313
ACCESSION NUMBER: 0000950170-24-008808
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240126
FILED AS OF DATE: 20240130
DATE AS OF CHANGE: 20240130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Angulo Gonzalez David
CENTRAL INDEX KEY: 0001644071
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36365
FILM NUMBER: 24578129
MAIL ADDRESS:
STREET 1: C/O SCYNEXIS, INC.
STREET 2: 3501 C TRICENTER BOULEVARD
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCYNEXIS INC
CENTRAL INDEX KEY: 0001178253
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562181648
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
BUSINESS PHONE: 201-884-5485
MAIL ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
4
1
ownership.xml
4
X0508
4
2024-01-26
0001178253
SCYNEXIS INC
SCYX
0001644071
Angulo Gonzalez David
1 EVERTRUST PLAZA
13TH FLOOR
JERSEY CITY
NJ
07302
true
true
false
false
Chief Executive Officer
false
Common Stock
2024-01-26
4
A
false
290590
0.00
A
479871
D
Employee Stock Option (Right to Buy)
1.86
2024-01-26
4
A
false
431030
0
A
2034-01-25
Common Stock
431030
431030
D
Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024.
Includes 4,100 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2023 (100 shares) and September 2023 (4,000 shares).
1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024.
/s/ Robert F. Joyce Jr., by Power of Attorney
2024-01-30